ArticleFrontiers in cardiovascular medicine2026
Undetectable brain natriuretic peptide as a marker of ultrasound-detected hypovolemia in patients with cancer on active treatment.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypovolemia is a common complication in patients undergoing cancer-related therapies, yet assessing volume status in this population is challenging because of confounding comorbidities. This retrospective study is the first of its kind to examine the relationship between hypovolemia, assessed by measuring inferior vena cava (IVC) diameter via transthoracic echocardiogram (TTE) as an indicator of fluid status, and brain natriuretic peptide (BNP) levels, a cardiac neurohormone released by the ventricles in response to increased pressure. We hypothesized that undetectable BNP levels (<10 pg/mL) would associate with small IVC diameters indicative of hypovolemia. Although our study revealed wide confidence intervals reflective of a small sample size, our findings suggest that undetectable BNP, a readily available laboratory marker, may serve as an indicator of hypovolemia when physical examination findings are inconclusive. In addition, our study was limited by the 2-week temporal variability of BNP and IVC measurements, which may potentially introduce bias because of the dynamic fluctuation of volume status. Further studies with larger cohorts and closer temporal alignment of BNP and TTE measurements are needed to validate these findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.